Ascletis Pharma Inc. (OTCMKTS:ASCLF – Get Free Report)’s stock price dropped 10.8% during mid-day trading on Friday . The stock traded as low as $1.07 and last traded at $1.07. 410 shares were traded during mid-day trading, a decline of 85% from the average session volume of 2,685 shares. The stock had previously closed at $1.20.
Ascletis Pharma Stock Performance
The stock has a 50 day simple moving average of $1.40 and a 200-day simple moving average of $1.77.
Ascletis Pharma Company Profile
Ascletis Pharma (OTCMKTS:ASCLF) is a clinical‐stage biopharmaceutical company headquartered in Hangzhou, China, dedicated to the research, development and commercialization of therapies for viral and liver diseases. Since its founding in 2013, the company has built an integrated platform spanning small‐molecule discovery, process chemistry and clinical development. Ascletis is listed on the Hong Kong Stock Exchange and maintains facilities for both clinical research and commercial manufacturing in Mainland China.
The company’s core pipeline focuses on direct‐acting antiviral agents targeting hepatitis B virus (HBV), hepatitis C virus (HCV) and human immunodeficiency virus (HIV).
Further Reading
- Five stocks we like better than Ascletis Pharma
- Popular’s Earnings Beat Shows Why This Bank Stock Keeps Climbing
- ABB’s Rotork Deal Could Put These Flow Control Stocks Back in Focus
- GE HealthCare Stock Climbs on Vital Diagnostics Demand
- Lost in Space: Why Aerospace Valuations Are Plummeting Right Now
Receive News & Ratings for Ascletis Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ascletis Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
